robert henric

robert henric

Followers 8
Following 16
US
[147 Pages Report] The Global Protein Crystallization and Crystallography Market size is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.Market Size Estimation;For calculating the global market value, segmental revenues were arrived at based on the revenue mapping of major players active in the protein crystallization  market.This process involved the following steps:Generating a list of the major global players operating in the marketMapping the annual revenues generated by 1-2 public companies from the protein crystallography market (or the nearest reported business unit/product/ service category)Estimating the revenue from the related market and extrapolating the global number as of 2019Calculating 100% of the global market value of the protein crystallization and crystallography marketThe market was also validated through a technology-based approachData Triangulation;After arriving at the proverall market size using the market size estimation processes explained above, the market was split into several segments and subsegments.To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable.The data was triangulated by studying various factors and trends from both the demand and supply sides of the protein crystallization market.Browse 142 market data Tables and 30 Figures spread through 147 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058Market Segmentation in Depth:By product and service, the consumables segment accounted for the largest market share in 2019.On the basis of product and service, the consumables segment accounted for the largest share of the protein crystallization market in 2019.This can be attributed to a large number of reagent kits and microplates used in proteomics research and the increasing demand for miniature screening plates in automated liquid handlers.By end user, the pharmaceutical companies segment accounted for the largest market share in 2019.The pharmaceutical companies segment accounted for the largest share of the protein crystallography market in 2019.This can be attributed to the increasing demand for protein-based drugs and the increasing demand for biologics in various application areas.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=147057058North America dominates the protein crystallization and crystallography market.The protein crystallography market is divided into five major regions, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
5
IT
[112 Pages Report] The Electronic Trial Master File Systems Market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the eTMF systems market.These methods were also used extensively to estimate the size of various sub-segments in the market.The research methodology used to estimate the market size includes the following:The key players in the industry and markets have been identified through extensive secondary researchThe industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processesAll percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesElectronic Trial Master File Systems Market – Data Triangulation;After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments.To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable.The data was triangulated by studying various factors and trends from both the demand and supply sides.Browse 79 market data Tables and 27 Figures spread through 112 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456Market Segmentation in Depth:Based on delivery mode, the market is segmented into on-premise and cloud-based eTMF.In 2018, the cloud-based eTMF segment accounted for the largest share of the market.
2
IT
[248 Pages Report] MarketsandMarkets forecasts the Industrial Centrifuges Market is projected to reach USD 11.06 billion, at a CAGR of 4.9% during the forecast period.The increasing demand for centrifuges in process industries, rising need for wastewater management solutions, and technological advancements in centrifuge systems are the major factors driving the growth of this market.Market Dynamics:Driver: Growing Need for Wastewater Management SolutionsWastewater contains a number of pollutants and contaminants that can cause health and environmental problems and can have economic and financial impacts if released into the environment without proper treatment.For instance, centrifuges are used in wastewater treatment for thickening primary sludge and dewatering sludge to create sludge solids.Factors such as growing environmental pollution levels, increasing population, and rapid urbanization and industrialization have increased the generation of industrial wastewater.Moreover, owing to the increasing global demand for potable water, the focus on effective wastewater treatment has increased significantly across the globe.As a result, there is a subsequent growth in government spending on water utilities and wastewater treatment, globally.Browse 201 Market Data Tables and 36 Figures spread through 248 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=59612221Sedimentation centrifuges segment to dominate the market in 2017Based on type, the global industrial centrifuges market is segmented into sedimentation centrifuges and filtering centrifuges.The wide range of industrial applications, ability to achieve high speeds, increase in oil and gas explorations, and rising need of wastewater treatment are the major factors contributing to the growth of this segment.Based on end user, the wastewater treatment plants segment is projected to register the highest CAGRBased on end user, the industrial centrifuges market is segmented into the chemical industry, food & beverage industry, metal industry, mining industry, pharmaceutical and biotechnology industries, power industry, pulp and paper industry, wastewater treatment plants, and water purification plants.
1
KR
[227 Pages Report] The Global Medical Supplies Market is projected to grow from USD 133.5 billion by 2025 from USD 132.6 billion in 2020, at a CAGR of 4.6%.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical supplies market.These methods were also used extensively to estimate the size of various subsegments in the market.The research methodology used to estimate the market size includes the following:The key players in the industry and market have been identified through extensive secondary research.The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.Data Triangulation;After arriving at the overall medical supplies market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments.To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable.The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical supplies industry.Browse 126 market data Tables and 45 Figures spread through 227 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238Market Segmentation in Depth:By type, the medical supplies market is segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies.The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period.
1
IT
[168 Pages Report] The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market. Recent Developments: In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals. In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan. Browse 64 market data Tables and 42 Figures spread through 168 Pages and in-depth TOC - Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375 Market Segmentation in Depth: Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Based on end user, the diabetes care devices (BRIC) market has been segmented into hospitals & specialty clinics and self/home healthcare.
2
IT
[136 Pages Report] The Global Breast Reconstruction Market size is expected to grow from USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the breast reconstruction market.These methods were also used to estimate the size of various subsegments in the market.The research methodology used to estimate the market size includes the following:The key players in the industry and markets have been identified through extensive secondary research.The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.Data Triangulation;After arriving at the overall breast reconstruction market size—using the market size estimation processes explained above—the market was split into several segments and subsegments.To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable.Browse 138 market data Tables and 29 Figures spread through 136 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593  Market Segmentation in Depth:Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix.The breast implants segment accounted for the largest market share in 2019.Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures.
IT
[151 Pages Report] The Hernia Repair Market is projected to reach USD 4.75 billion, at a CAGR of 3.0% during the forecast period.Market Segmentation in Detailed:On the basis of product, the hernia repair market is segmented into mesh and mesh fixators.In 2018, the biologic mesh segment is expected to register the highest growth rate in the hernia mesh market.The increasing number of clinical trials to establish safety and the benefits of biologic meshes coupled with technological advancements to reduce ‘could be’ issues with this mesh are some of the factors triggering the growth of this segment.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203245450Market DynamicsThe increasing number of hernia repair procedures, advantages of mesh in hernia repair, and technological advancements are the major factors driving the hernia repair market.In addition, emerging markets are expected to emerge as potential areas of opportunity for players in this market.Driver: Increasing hernia prevalence;The growing prevalence of hernia is the main driving force for the growth of the hernia mesh repair market.This is mainly attributed to the overall increase in population, specifically geriatric and obese population, and improvements in healthcare systems that have enabled the early detection and treatment of hernia.Age contributes significantly to the risk of hernia by retarding the body’s capabilities and natural healing abilities over time.According to a registered study in the UK, the prevalence of hernia was found to increase with age, from 5% in the 25¡V34 age group to:10% in the 35-44 age group18% in the 45-54 age group24% in the 55-64 age group31% in the 65-74 age groupIn addition, the incidence of hernia among men aged 75 years and above was found to be 45%.
4
IT
The Kidney Function Test Market is projected to reach $790.1 Million, growing at a CAGR of 6.1% during the forecast period.According to the new market research report "Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User - Global Forecast", published by MarketsandMarkets™.The key factors driving the growth of this market include the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and rise in alcohol consumption.Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40239083Research Methodology:Top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall kidney function test market.Various secondary sources such as associations like the American Academy of Family Physicians (AAFP), University of Utah, European Renal Care Providers Association (ERCPA), Association of Clinical Biochemists in Ireland (ACBI), Association of Physicians of India (API), American Urological Association (AUA), Centers for Disease Control and Prevention (CDC), National Kidney Foundation, World Health Organization (WHO), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this marketMarket Segmentation in-Detailed:By product, the market is categorized into dipsticks, reagents, and disposables.Dipsticks are expected to account for the largest share of the market in 2017, they are also expected to grow at the highest CAGR during the forecast period.The large share and high growth rate of this segment can be attributed to factors such as the cost-effectiveness of dipstick testing and its widespread applications across specializations.On the basis of end users, the Renal Function Test Market is segmented into hospitals, diagnostics laboratory, and research laboratories & institutes.The hospitals segment is the largest and fastest growing segment of the market.Factors contributing to the large share and high growth rate of this segment include the increasing number of awareness campaigns about kidney function tests and the growing focus of emerging economies on increasing the number of hospitals in these regions.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=40239083Objectives of the Study:To define, describe, segment, and forecast the global kidney function test market by product, type, end user, and regionTo provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)To strategically analyze micro-markets with respect to the individual growth trends, prospects, and contributions to the overall marketTo analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leadersTo profile the key players and comprehensively analyze their product portfolios, market shares, and core competencies in the global kidney function test marketWorldwide Geographical Segmentation in-detailed:The Kidney Function Test Market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
1
IN
MarketsandMarkets™ published a report titled, "COVID-19 Impact on Critical Care Device Market by Device (High-Impact Products (Ventilators, Patient Monitors, Infusion Pumps, Hyperbaric Oxygen Therapy Devices and Sleep Apnea Devices) and Low-Impact Products (Anesthesia Machines, Defibrillators and Blood Warmers)) and Region – Global Forecast to 2021".Based on their findings, the global Critical Care Devices Market size is expected to reach USD 27.29 billion by 2021 from an estimated value of USD 37.97 billion in 2020.The critical care devices market is expected to witness a growth of 44.1% from 2019 to 2020.The market for critical care devices is driven primarily by the increasing number of ICU beds owing to the continuously rising COVID-19 cases, increasing demand for ventilators for effective management of critical COVID-19 patients, and ease of regulatory requirements to facilitate the production of critical care devices.In addition, the development of low-cost ventilators and the expected increase in healthcare budgets offer significant growth opportunities for players operating in the critical care devices market.However, disruption of supply chain & logistics due to the rapid spread of coronavirus is likely to challenge the growth of this market.Request for PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216430576The ventilators segment is expected to grow at the highest CAGR during the forecast periodBased on products, the critical care devices market is segmented into ventilators & supplies, sleep apnea devices, patient monitors, hyperbaric oxygen therapy devices, infusion pumps, defibrillators, anesthesia machines, blood warmers, and other critical care devices supplies.To meet the global demand, Getinge will temporarily increase its production of advanced ICU-ventilators by 160% in 2020, to 26,000 ventilators in total.
5
IN
According to the new market research report "Particle Counter Market by Type (Airborne, Liquid), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids, IAQM), End User (Life Sciences & Medical Devices, Semiconductor, Automotive), Region - Global Forecast to 2024", published by MarketsandMarkets™, the Particle Counter Market is projected to grow at a CAGR of 11.0% during the forecast period, to reach USD 580 million by 2024 from USD 340 million in 2019.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221564539particle counters marketThe Factors such as robust growth in applied markets, the favorable regulatory scenario, and growing focus on the quality of food products are driving the growth of the market during the forecast period.The airborne particle counters segment accounted for the largest share of the Market, by type, in 2018The airborne particle counters segment accounted for the largest share of the market in 2018.The large market share of this segment can be attributed to the growing monitoring of cleanrooms for the semiconductor, aerospace, pharmaceuticals, and medical devices industries; low cost of remote particle counters; and rising awareness of indoor quality monitoring.Browse in-depth TOC on "Particle Counter Market"212 – Tables26 – Figures198 – PagesCleanroom monitoring segment accounted for the largest share of the particle counters applications market in 2018The cleanroom monitoring segment accounted for the largest share of the Particle Counters Market, by application, in 2018.Technological advances in industries such as pharmaceutical, biotech, medical devices, automotive, and aerospace are increasing the demand for quality assurance and stringent regulations of manufacturing environments to ensure product quality.This has driven the demand for cleanroom monitoring and, by extension, particle counters.Thus, the growth of the market for cleanroom monitoring will be tied directly to the growth of industries that use cleanrooms.Life sciences & medical device industries are the largest end users of the Particle Counters MarketIn 2018, the life sciences & medical device industry segment accounted for the largest share of the market.Market growth is largely driven by the growing volume of compounds to be detected for the presence of impurities in pharmaceutical samples, increasing production of pharmaceutical formulations, stringent safety regulations, and increased R expenditure.
1
IN
According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecast”, published by MarketsandMarkets™.Revenue Growth of the Market:The Global Viral Clearance Market is expected to reach $724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.Market Segmentation:-On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications.In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.On the basis of the method, the viral clearance market is segmented into viral removal and viral inactivation.In 2018, the viral removal segment is expected to account for the largest share of the global market due to the growth in the biopharmaceutical R activities; the high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences researchDownload PDF (Please provide your specific interest in this report so as to help you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197Market Growth Drivers:Growth in the Pharmaceutical and Biotechnology IndustriesIncreasing Number of Drug LaunchesHigh Incidence and Large Economic Burden of Chronic DiseasesPossibility of Cell Culture ContaminationAdvancements in Nanofiltration TechnologyRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197Geographical Analysis:The North American region is expected to account for the largest share of the market in 2018.However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.Major Key Players In Global Viral Clearance Market:Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
2
IN
The Global Veterinary Chemistry Analyzer Market is estimated to grow at a CAGR of 8.7% to reach the US $1,205.2 million.The Growth in this Veterinary Chemistry Analyzer Market is majorly attributed to factors such as growing livestock and companion animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, raising awareness about zoonotic diseases, and an increasing number of veterinary practitioners across the globe.Request for Sample Report @https://www.marketsandmarkets.com/requestsampleNew.asp?id=48798056Global Veterinary Chemistry Analyzer Market Segmentation:On the basis of products, the Veterinary Chemistry Analyzer Market is segmented into instruments (including chemistry analyzers, urine analyzers, glucometers, and blood gas & electrolyte analyzers) and consumables (including panels, kits, test strips, and reagents).The consumables segment accounted for the largest share of the global market and is expected to register the highest CAGR during the forecast period.Based on application, the market is segmented into blood chemistry analysis, urinalysis, glucose monitoring, and blood gas & electrolyte analysis.The blood chemistry analysis segment accounted for the largest share of the global veterinary chemistry analyzers market.The large share of this segment is mainly attributed to the growing prevalence of animal diseases, rising awareness about zoonotic diseases, and increasing number of veterinary practitioners across the globe.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48798056Geographic AnalysisGeographically, the veterinary chemistry analyzer market is categorized into developed and emerging markets.The emerging markets (including China, India, and Latin America) segment is expected to witness the highest growth rate during the forecast period.Growth in these markets can be attributed to the rising animal population, increasing demand for animal-derived food products, growing per capita animal health expenditure (especially in India, Latin America, and China), growing pet adoption, and rising awareness regarding animal health and welfare.The market is dominated by IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), and Heska Corporation (U.S.).
3
ID
The Global Endoscope Reprocessing Market is expected to reach USD 2.15 Billion, at a CAGR of 8.6%According to the new market research report “Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) — Global Forecast”, published by MarketsandMarkets™.Factors such as high risk of infections associated with improper sterilization of endoscopes, increasing investments, funds, and grants by government bodies across the globe, rising number of hospitals and growing hospital investments in endoscopy instruments, and rising prevalence of diseases that require endoscopy procedures are driving the growth of the Endoscope Reprocessing Market during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994Objectives of the Study:To define, describe, and measure the global endoscope reprocessing market by products, end user, and regionTo provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the marketTo analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global marketMarket Segmentation in Depth:On the basis of products, the market is segmented into high-level disinfectants and test strips; detergents and wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges).The high-level disinfectants and test strips segment is expected to account for the largest share of the global Endoscope Reprocessing Market.On the basis of the end user, the Endoscope Reprocessing Market has been segmented into hospitals, ambulatory surgery centers, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers).The ambulatory surgery centers (ASCs) segment, on the other hand, is expected to be the fastest-growing segment during the forecast period.The high growth in this segment can be attributed to the increase in the number of endoscopic procedures performed in ASCs, and the rising preference of ASCs over hospitals.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219094994Geographical Analysis:North America accounted for the largest share of the Endoscope Reprocessing Market in 2017, followed by Europe.In the US, the Endoscope Reprocessing Market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections.In Canada, the growth of the Endoscope Reprocessing Market is driven by the availability of physician bonuses and the implementation of a new funding model for Canadian hospitals.The various players in the Endoscope Reprocessing Market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.
2
IN
According to the new market research report "Orthodontic Supplies Market by Product (Removable, Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Ni-Ti, Stainless Steel), Anchorage (Buccal Tube, Band), Ligature (Elastomeric, Wire)), Retainers), Patient, and Region - Global Forecast", published by MarketsandMarkets™.Revenue Growth Opportunities & Drivers:Orthodontic Supplies Market is expected to reach USD 6.63 Billion by 2023 from USD 4.32 Billion in 2018, at a CAGR of 8.9%Driver: Growing number of patients with malocclusions, jaw diseases, tooth decay/tooth loss, and jaw painOrthodontic products are used to straighten and align teeth, correct abnormal bite patterns, and close unsightly gaps.Orthodontic devices such as fixed and removable braces are widely adopted by people with malocclusions and jaw diseases.With rapid growth in the number of people suffering from these conditions across the globe, the demand for orthodontic braces is expected to increase in the coming years.Studies show that there is a high prevalence of malocclusion and jaw deformities (such as cross bite, open bite, spacing problems, deep bite, crowding issues, and teeth rotation problems) across several regions.The prevalence of these dental conditions is also high in both adolescents as well as adults.Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236529189orthodontic supplies marketMarket Segmentation in-Detailed:-On the basis of products, the market is categorized into fixed braces, removable braces/aligners, adhesives, and accessories.The fixed braces segment is expected to account for the largest share of the global market in 2018.Factors such as better affordability as compared to removable braces, effective outcomes, and the huge demand for these braces in emerging countries such as India, China, and Brazil are propelling growth in this segment.On the basis of patients, the market is segmented into children and teenagers and adults.
1
IN
[141 Pages Report] The Therapeutic Drug Monitoring Market is projected to reach to reach USD 1.63 billion, at a CAGR of 5.9% during the forecast period.Market DynamicsDriver:Use of TDM in traditional anticancer therapiesTDM provides valuable guidance for the dose adjustment of antibiotics, immunosuppressants, antiepileptics, and other drugs.However, its use in traditional anticancer therapies has been limited.The requirement of multiple blood samples to adequately define the systemic exposure of anticancer drugs is the major issue encountered while testing for anticancer therapies.Drugs in blood samples have a short elimination half-life and are given by intermittent intravenous injections; this makes the entire monitoring process difficult to analyze.Recent evidence indicates that certain PK parameters, including trough levels, are correlated with clinical outcomes for many cytotoxic agents, including imatinib, sunitinib, rituximab, and cetuximab.Although current evidence is not sufficient to make TDM a compulsory practice, investigations with encouraging results will have a practical place in the clinical care of patients with cancer.With the increasing incidence of cancer and focus on reducing the adverse effects of drugs, the monitoring of antineoplastic drugs is expected to gain more importance in the treatment of cancer.Browse 145 market data Tables and 23 Figures spread through 141 Pages and in-depth TOC – Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443  Based on product, the consumables segment is expected to grow at the highest CAGR during the forecast periodOn the basis of product, the global therapeutic drug monitoring market is segmented into consumables and equipment.
1
ID
According to the new market research report "Humanized Mouse and Rat Model Market by Type (Genetic, Cell-Based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoesis, Oncology, Immunology & Infectious Diseases) & End User (Pharmaceutical & Biotechnology Companies, CRO)) - Global Forecast", published by MarketsandMarkets™.The Humanized Mouse Model Market is projected to reach USD 128.9 Million, at a CAGR of 9.9% during the forecast period.The Humanized Rat Model market is expected to reach USD 8.9 Million by 2022 from USD 5.9 Million in 2017, at a CAGR of 8.4% during the forecast period.Market Dynamics:Driver: Growing demand for personalized medicinePersonalized medicine is the process of developing tailored medicines to target individualized treatment and care based on personal and genetic variations.These medicines are designed through the use of animal models, particularly mice models.Immune-deficient models are transplanted with human tissues and the disease expressed is recorded.This is followed by treating the model with a whole series of drugs or gene therapies to find the most suitable treatment, thus generating suitable or personalized medicine for patients.Currently, cancer is a major burden on the healthcare systems across geographies.By 2020, the direct/indirect cost of cancer is estimated to be USD 300 billion in the US.Several in vitro and in vivo strategies are being developed in an attempt to combat the rising prevalence of cancer and offer effective treatments to patients.
2
IN
Growth in this market is primarily attributed to the rising geriatric population and the subsequent increase in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR. Market Dynamics Driver: Rising geriatric population and the subsequent growth in the prevalence of CVD Over the years, there has been a significant increase in the geriatric population across the globe. According to the UN World Population Ageing Report 2017, the global geriatric population (aged 60 years and above) is expected to reach 2.1 billion by 2050 from 962 million in 2017. As this population segment is highly susceptible to CVD and other target diseases, the demand for advanced diagnostic and treatment options is expected to increase in the coming years. In this scenario, the demand for fractional flow reserve is likely to increase as it provides various benefits, such as assessing if the stenosis is required, which in turn helps in avoiding surgeries (in cases where stenosis is not needed). Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023 Report Objectives in Detailed: To define, describe, and forecast the fractional flow reserve market by technology, application, and region To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, and challenges) To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players By technology, the invasive monitoring segment is estimated to hold the largest share of the fractional flow reserve market Based on technology, the fractional flow reserve market is segmented into invasive and non-invasive monitoring.
ID
The Pen Needles Market is expected to reach $1.8 billion by 2024 from an estimated $1.1 billion in 2019, at a CAGR of 10.8% during the forecast period.The study involved four major activities in estimating the current market size for pen needles.The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.Secondary Research:In the secondary research process, various secondary sources such as the WHO, International Diabetes Federation, World Bank, Global Burden of Disease Study, Food and Drug Administration, American Diabetes Association, American Association of Diabetes Educators, Centers for Disease Control and Prevention, Diabetes Canada, Statistics Canada, European Association for the Study of Diabetes, European Society of Endocrinology, Diabetes UK, National Health Service, OECD Health Statistics, Asian Association for the Study of Diabetes, ASEAN Federation of Endocrine Societies.Primary Research:In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pen needles market.Download PDF (Please share your specific interest to serve you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613Market Segmentation:On the basis of therapy, the pen needles market is segmented into insulin, GLP-1, growth hormone, and other therapies such as osteoporosis, fertility, and obesity.The insulin therapy segment is expected to grow at a higher CAGR during the forecast period primarily due to the high and growing diabetic population globally.Since pen needles need to be replaced after every injection, the rising use of insulin pens is a major factor driving the demand for pen needles.
1
ID
The major factors driving the growth of the Leukapheresis Market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations. Leukapheresis Market Major Drivers; Increasing incidence and prevalence of leukemia; Globally, the incidence of leukemia has risen significantly. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015). In the US alone, ~44,000 units of blood are required every day in hospitals and emergency treatment facilities. The requirement of leukocytes/WBCs is increasing with the increase in demand for leukopaks in clinical research and the rising number of clinical trials for the development of CAR-T therapy for leukemia. Browse 134 market data Tables and 49 Figures spread through 194 Pages and in-depth TOC  – Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148   Leukapheresis Market Segmentation: By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018 On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters.
1
ID
The report "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast", report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.The Global High-Resolution Melting Analysis Market is expected to reach $302.1 Million, at a CAGR of 3.1% during the forecast periodRising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216456020On the basis of product & service:The Market is segmented into instruments, reagents & consumables, and software & services.The reagents and consumables segment dominated the market in 2016; and is expected to continue to dominate the market during the forecast period.The segment is also expected to grow at the highest CAGR during the forecast period.On the basis of application:The High-Resolution Melting Analysis Market is broadly classified into SNP genotyping, mutation scanning, species identification, pathogen identification, epigenetics, and other applications.In 2016, the SNP genotyping segment accounted for the largest share of the Market.This can be attributed to the wide range of applications of SNP genotyping in the diagnosis of genetic and autoimmune diseases, study of the variations in drug responses, drug discovery & development, and the identification of genetic variations in plant or animal genomes.On the basis of end user:The High-Resolution Melting Analysis Market is segmented into research laboratories & academic institutes, hospitals & diagnostics centers, pharmaceutical & biotechnology companies, and other end users.In 2016, the research laboratories & academic institutes segment accounted for the largest share of the global market.
1
IN
[150 Pages Report] The COVID-19 impact on Medical Supplies Market is expected to reach USD ~100 billion by 2021 from an estimated value of USD ~78 billion in 2019, growing at a CAGR of ~13.4% during the forecast period.This study involved four major activities in estimating the current size of the COVID-19 impact on the medical supplies market.Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.After that, market breakdown and data triangulation procedures were used to evaluate the size of segments and subsegments.Browse in-depth TOC on “COVID-19 impact on Medical Supplies Market”97 – Tables20 – Figures150 – PagesThe market for medical supplies is driven primarily by the growing awareness on environmental & personal hygiene leading to rising demand for disinfectants , expansion of healthcare settings owing to increasing COVID 19 patients, increased requirement of PPE kits & N95 masks globally, rising demand for ventilators, and increasing demand for diagnostic supplies.However, delays in non-urgent treatment and surgical procedures and impact on supply chain and logistics due to lockdown is likely to restrain the growth of this market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158189339  The disinfectant segment is projected to grow at the highest CAGR during the forecast periodBased on products, the market is segmented into intubation and ventilation supplies, disinfectant, personal protective equipment, diagnostic supplies, sterilization supplies, infusion and injectable supplies, dialysis supplies, wound care supplies, radiology supplies, and other medical supplies.The disinfectant segment is expected to grow at the highest rate during the forecast period.
1
ID
[146 Pages Report] The Global Women’s Healthcare Market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period (2019–2024).Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the women’s healthcare market.The research methodology used to estimate the market size includes the following:The key players in the industry and markets have been identified through extensive secondary researchThe revenue generated from the sales of respective products from the respective geographies in the market by leading players were aggregated to get the market value for individual products at the global level.The global market values obtained for each product were added together to get the total global market value for the market.All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136585329Prolia is the largest and fastest-growing segment of the market.Based on drug, the market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28).Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.The postmenopausal osteoporosis segment is expected to grow at the highest CAGR during the forecast periodOn the basis of application, the market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications.Furthermore, the focus of pharmaceutical players on providing effective drugs for postmenopausal osteoporosis also supports the growth of this segment.The postmenopausal osteoporosis segment also holds the largest share of the market owing to these factors.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=136585329Which geographical region is dominating the global women’s healthcare market?The global Women’s healthcare market is segmented into four major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa.
3
IN
[300 Pages Report] The Track and Trace Solutions Market is projected to reach USD 4.21 billion by 2024 from USD 2.16 billion in 2019, at a CAGR of 14.2%.This study involved the extensive use of both primary and secondary sources.The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, competitive leadership mapping, key market dynamics, and key player strategies.Secondary Research:Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies.Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the track and trace solutions market.Primary Research:In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.Industry experts from the supply side include suppliers, distributors, CEOs, vice presidents, marketing and sales directors, business development managers, and technology and innovation directors of track and trace solutions providers, whereas, industry experts from the demand side include industry experts such as vice presidents & directors of pharmaceutical, biopharmaceutical, and medical device companies, contract manufacturing organizations, directors of cosmetic companies, directors of clinical laboratories, software application experts, and other related key opinion leaders.Browse 264 market data Tables and 52 Figures spread through 300 Pages and in-depth TOC = Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570The pharmaceutical & biopharmaceutical companies segment is expected to account for the largest share of the track and trace end user market in 2019On the basis of end user, pharmaceutical & biopharmaceutical companies segment is expected to account for the largest share of the market in 2019.The large share of the market is mainly due to factors such as the growing number of counterfeit drugs, specifically in developing countries, and stringent regulations for thePharmaceutical Packaging industry.The serialization segment accounted for the largest share of the track and trace solutions market in 2019Based on applications, the market is segmented into serialization; aggregation; and tracking, tracing, & reporting.The serialization segment accounted for the largest share of the applications market.
ID
[139 Pages Report] The Gynecology Surgical Instrument Market is expected to reach USD 2.44 Billion, at a CAGR of 7.1% during the forecast period.Major factors driving the growth of this market include a high incidence of gynecological diseases, increasing awareness of gynecological diseases, and rising government investments for providing advanced healthcare facilities & services.In addition, emerging Asian markets have opened an array of opportunities for players in this market.However, the increasing preference for robotic surgeries may restrain the growth of this market.Browse 104 market data tables and 40 figures spread through 139 pages and in-depth TOC - Request Research Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=122824797Market Segmentation in Depth:Based on product, the market is segmented into forceps, scissors, needle holders, dilators, trocars, vaginal speculums, and other instruments.The forceps segment dominated the market by holding the largest share in 2016 and also experience the highest growth during the forecast period.The high growth in this segment is attributed to the increase in the number of gynecological surgeries, and the repeated use of forceps in most gynecological surgeries.Based on application, the gynecology surgical instrument market is further divided into laparoscopy, hysteroscopy, dilation and curettage, colposcopy, and other applications.Laparoscopy forms the largest and fastest-growing application segment of the global market.
2
IN
[47 Pages Report] The North American Radiation Protection Apron Market is projected to reach USD 49 million by 2024 from USD 36 million in 2019, at a CAGR of 6.6% during the forecast period.Market Size Estimation:Both top-down and bottom-up approaches were used to estimate and validate the total size of the market.These methods were also used extensively to estimate the size of various sub-segments in the market.The research methodology used to estimate the market size includes the following:The key players in the industry and markets have been identified through extensive secondary researchThe industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processesAll percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesPlease share your specific interest to serve you better: https://www.marketsandmarkets.com/requestsampleNew.asp?id=124332526Front protection aprons segment accounted for the largest share of the market in 2018.Based on type, the medical radiation protection aprons market is segmented into front protection aprons, vest and skirt aprons, and other aprons.In 2018, the front protection aprons segment accounted for the largest market share primarily due to the wide availability and high usage of these aprons in dental clinics and hospital settings.Recent Developments:In 2019, Infab Corporation (US) received certification from Perry Johnson Registrars, Inc., an accredited certification body, to design and develop radiation protective apparel, accessories, barriers, apron racks, and gloves.In 2018, Infab Corporation (US) announced that it would launch its revolution premium vest and skirts with interior pockets in January 2019.In 2018, Infab Corporation (US) expanded its revolution aprons with the latest revolution color—light blue serenity.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124332526US accounted for the largest share of the North American Radiation Protection Aprons Market in 2018.The US accounted for the largest share of the market in 2018.The large share of the US can primarily be attributed to the rising incidence of cancer, growing geriatric population, and the strong presence of key players in the country.Apart from this, increasing safety awareness among people working in radiation-prone environments is also expected to drive the overall medical radiation protection aprons market in the country.Prominent players in the medical radiation protection aprons market include Infab Corporation (US), Bar·Ray Products (US), Burlington Medical LLC (US), Shielding International, Inc. (US), and AliMed, Inc. (US).
2
IN
The Back-end Revenue Cycle Management Market is projected to reach USD 10.4 billion, at a CAGR of 5.0%Market DynamicsGrowing importance of denials management:To reduce costs and maximize profits, insurance companies are increasingly denying claims as well as coverage to patients being treated for chronic or persistent illnesses.This is putting an extra burden on healthcare providers to manage operating costs, and in turn is supporting the adoption of back-end revenue cycle management solutions (with a growing number of healthcare providers focusing on properly analyzing denied claims and appealing them).Many healthcare providers across the globe still use manual and paper-oriented approaches to manage denials.This results in errors, delayed follow-ups, and miscommunication between healthcare providers and insurance companies.The use of back-end revenue cycle management solutions over manual and paper-oriented approaches can not only help healthcare providers overcome these issues but also help them save significant costs.As a result, the demand for back-end revenue cycle management solutions is expected to increase among end users during the forecast period.Back-end Revenue Cycle Management MarketDownload PDF (Back-end RCM Market):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204439794The research report segments the Back-end Revenue Cycle Management Market based on product & service, delivery mode, software type, end users, and regions.By product & service, the services segment is expected grow at the highest rate during the forecast periodOn the basis of product & service, the market is segmented into software and services.The services segment is estimated to witness the highest CAGR during 2018–2023.
2
IN
The Global Medical Vacuum System Market is projected to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2018, at a CAGR of 6.3 % during the forecast period.The Research Report "Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) - Global Forecast to 2024".Market Estimation Methodology:A detailed market estimation approach was followed to estimate and validate the size of the global medical vacuum systems market and other dependent submarkets.The key players in the global medical vacuum systems market were identified through secondary research, and their global market shares were determined through primary and secondary research.The research methodology includes the study of the annual and quarterly financial reports of top market players as well as interviews with industry experts to gather key insights on various market segments and subsegments.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150008017By product type, standalone vacuum systems account for the largest share of the medical vacuum system marketOn the basis of product type, the market is segmented into standalone vacuum systems centralized vacuum systems, portable vacuum systems, and accessories.The standalone vacuum systems segment is expected to hold the largest share of the market mainly due to the huge end-user base for compact/standalone products, high adoption of these systems among dental clinics and research labs, and their advantages in the aforementioned settings.Therapeutic applications dominate the medical vacuum system market, by applicationOn the basis of application, the global medical vacuum systems industry is segmented into pharma-biotech manufacturing, therapeutic applications, diagnostic applications, and research applications.The therapeutic applications segment accounted for the largest share of the market in 2018 due to the rising incidence of dental caries and other periodontal diseases, increasing use of NPWT for diabetic ulcer management, and the increasing number of target medical procedures across major markets.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=150008017North America accounts for the largest share of the medical vacuum systems marketThis report covers the medical vacuum systems market across five major geographies North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.North America is expected to command the largest share of the medical vacuum systems market mainly due to stringent regulatory norms for cleanroom maintenance, manufacturing guidelines and surgical protocols, technological advancement, the rising number of target surgical procedures, a growing end-user base, and increasing expenditure healthcare infrastructure in the region.Key Market Players:Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are the major players operating in the medical vacuum systems market.
2
ID
[146 Pages Report]The Fiducial Markers Market is projected to USD 123 million by 2025 from USD 95 million in 2019, at a CAGR of 4.5% during the forecast period of 2019 to 2025.According to the new market research report "Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End-user (Hospitals, Outpatient Facilities) - Global Forecast to 2025", published by MarketsandMarkets™.Fiducial Markets Market - Global ForecastDownload PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180673710Market Segmentation in Detailed:The ultrasound modality segment will register significant growth over the forecast periodOn the basis of modality, the market is classified into CT/CBCT, MRI, ultrasound, and radiotherapy.Technological advancements and the rising preference for minimally invasive procedures have supported the high growth of the ultrasound modality segment.Prostate cancer commanded the leading market share due to the rising preference for radiotherapy treatmentBy cancer type, the fiducial markers market is segmented into prostate cancer, lung cancer, breast cancer, gastric cancer, and others.The prostate cancer segment is expected to dominate the market.The ongoing modernization and expansion of healthcare infrastructure, growing medical tourism, and improving research capabilities are expected to improve radiotherapy accessibility, further supporting market growth.Objectives of the Study in Depth:To define, describe, and forecast the market on the basis of product, cancer type, modality, end user, and regionTo provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the total marketTo analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leadersTo forecast the sizes of market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & AfricaRequest Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=180673710Geographical Analysis in Detailed:The Asia Pacific is expected to register significant growth over the forecast period owing to the rising patient poolThe Fiducial Markers Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.North America is projected to hold the largest share of the regional market for fiducial markers in 2019.This is attributed to the expansion of the target patient population, favorable reimbursement scenario, greater accessibility to radiotherapy procedures, and the presence of major players in this region.Key Players in worldwide Industry:The major players in the market include CIVCO Radiotherapy (US), IZI Medical Products (US), Boston Scientific Corporation (US), Naslund Medical AB (Sweden), and IBA (Belgium).
3
ID
[172 Pages Report] The Global Embolic Protection Devices Market is projected to reach USD 604.9 Million by 2023 at a CAGR of 8.3% during the forecast period.Research Methodology:Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets.Major players in the market were identified through secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research.Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives.The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803Market Segmentation in Depth:On the basis of type, the distal filter devices segment is expected to grow at the highest CAGR during the forecast period.The high growth of this segment can primarily be attributed to the procedural benefits distal filter devices offer, such as ease of use, enhanced visibility, and crossing profile of the device.On the basis of material, nitinol accounted for the largest share of the market.The super-elastic material and braided nitinol design provide full wall apposition and this quality is expected to drive the growth of nitinol in the global market during the forecast period.On the basis of application, the embolic protection market is segmented into cardiovascular, neurovascular, and peripheral vascular diseases.
1
ID
The Global Amniotic Products Market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%.Amniotic Products Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments.The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market.On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191575976Industry Segmentation in Depth:The amniotic membranes segment is expected to grow at the highest CAGR during the forecast period.On the basis of type, the amniotic products market is categorized into two segments, amniotic membranes and amniotic suspensions.The amniotic membranes segment accounted for the largest share of the amniotic products market in 2019.Amniotic membranes have anti-inflammatory, anti-angiogenic, anti-fibrotic, and anti-microbial properties.This is a major factor driving market growth.Hospitals & ASCs are the largest end users of amniotic products.Based on end user, the amniotic products market is segmented into hospitals & ASCs and other end users.Factors such as the high demand for wound care biologics (including amniotic tissue products) in hospitals and ASCs, the high patient inflow in this care setting, and the availability of reimbursements are driving the growth of this segment.Request Research Sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191575976North America was the largest regional market for amniotic products in 2019.The global amniotic products market has been divided into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
2
More

Top